Trovagene develops drug-based therapeutics that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers... Read more
Trovagene develops drug-based therapeutics that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers... Read more
News
Mar 04, 2026
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's employee count changed from 33 in Feb 2025 to 31 in Feb 2026
Nov 07, 2025
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $545K in Jun 2025 to $500K in Sep 2025
May 08, 2025
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $683K in Dec 2024 to $587K in Mar 2025
Feb 28, 2025
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's employee count changed from 32 in Feb 2024 to 33 in Feb 2025
Feb 04, 2025
Openpr
Cardiff Oncology: Liquid Biopsy Market In-depth Insights, Business Opportunities and top companies Analysis forecast by 2032 | Biocept, Inc., Qiagen N.V., Trovagene
Nov 08, 2024
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $665K in Jun 2024 to $689K in Sep 2024
May 02, 2024
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $488K in Dec 2023 to $610K in Mar 2024
Mar 01, 2024
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $460K in Sep 2023 to $488K in Dec 2023
Nov 02, 2023
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $412K in Jun 2023 to $460K in Sep 2023
Aug 09, 2023
Owler
Cardiff Oncology, Inc.: Cardiff Oncology's revenue changed from $395K in Mar 2023 to $412K in Jun 2023
Cardiff Oncology Competitors
1
2
3
4
5
6
7
8
9
10